Olema Pharmaceuticals (OLMA)
(Delayed Data from NSDQ)
$11.85 USD
-0.89 (-6.99%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $11.86 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Olema Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -96.66 | -104.79 | -71.10 | -22.12 | -4.32 |
Depreciation/Amortization & Depletion | 0.38 | -0.43 | 0.44 | 0.01 | 0.01 |
Net Change from Assets/Liabilities | -0.59 | 3.02 | 2.83 | -1.51 | 1.23 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.14 | 20.13 | 17.14 | 3.75 | 0.00 |
Net Cash From Operating Activities | -83.73 | -82.07 | -50.69 | -19.87 | -3.08 |
Property & Equipment | 0.01 | -0.36 | -1.58 | -0.06 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -4.87 | 91.84 | -273.86 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.85 | 91.48 | -275.44 | -0.06 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 133.42 | 0.48 | 1.39 | 355.32 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 3.09 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 133.42 | 0.48 | 1.39 | 358.40 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 44.84 | 9.89 | -324.74 | 338.48 | -3.08 |
Cash at Beginning of Period | 23.70 | 13.81 | 338.55 | 0.07 | 3.15 |
Cash at End of Period | 68.54 | 23.70 | 13.81 | 338.55 | 0.07 |
Diluted Net EPS | -2.14 | -2.62 | -1.80 | -3.42 | -1.66 |
Fiscal Year End for Olema Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -61.35 | -30.97 | -96.66 | -69.88 | -48.38 |
Depreciation/Amortization & Depletion | 0.18 | 0.09 | 0.38 | 0.29 | 0.20 |
Net Change from Assets/Liabilities | 3.46 | 4.54 | -0.59 | -6.39 | -1.81 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.66 | 2.84 | 13.14 | 10.74 | 7.49 |
Net Cash From Operating Activities | -51.05 | -23.50 | -83.73 | -65.25 | -42.51 |
Property & Equipment | -0.16 | -0.15 | 0.01 | 0.01 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -24.86 | -19.99 | -4.87 | 26.05 | 51.50 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -25.02 | -20.14 | -4.85 | 26.06 | 51.50 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 24.43 | 8.82 | 133.42 | 132.89 | 2.26 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 24.43 | 8.82 | 133.42 | 132.89 | 2.26 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -51.65 | -34.82 | 44.84 | 93.71 | 11.26 |
Cash at Beginning of Period | 68.54 | 68.54 | 23.70 | 23.70 | 23.70 |
Cash at End of Period | 16.89 | 33.72 | 68.54 | 117.41 | 34.96 |
Diluted Net EPS | -0.54 | -0.56 | -0.47 | -0.48 | -0.49 |